F Zengerling
Overview
Explore the profile of F Zengerling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
41
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schreen W, Zengerling F
Urologie
. 2023 Nov;
62(12):1322-1325.
PMID: 37949976
No abstract available.
2.
Schreen W, Huch B, Vogele D, Zengerling F
Urologie
. 2023 Oct;
62(12):1309-1314.
PMID: 37816873
No abstract available.
3.
Brandt M, Ruf C, Dieckmann K, Syring I, Ruckes C, Nestler T, et al.
World J Urol
. 2021 Dec;
40(2):327-334.
PMID: 34854948
Purpose: Clinical stage I (CSI) testicular germ cell tumors (TGCT) represents disease confined to the testis without metastasis and CSIS is defined as persistently elevated tumor markers (TM) after orchiectomy,...
4.
5.
6.
Schrader M, Zengerling F, Hakenberg O, Protzel C
Urologe A
. 2016 Aug;
55(9):1192-8.
PMID: 27488741
Background: The second-opinion network for testicular cancer is an internet-based platform addressing physicians treating testicular cancer patients. They are offered a second-opinion before determining further therapy after orchiectomy and completion...
7.
8.
Breunig C, Zengerling F, Schnoller T, Schrader M, Jentzmik F
Aktuelle Urol
. 2016 Apr;
47(2):136-40.
PMID: 27078144
Background: In Germany, testicular cancer accounts for about 1-2% of all malignant tumours. Although, therefore, this is a rare tumour, it assumes an exceptional position among malignant tumours in several...
9.
10.
Schnoller T, Zengerling F, Hirning C, Jentzmik F
Urologe A
. 2015 Apr;
54(7):992-7.
PMID: 25894992
Background: Urothelial cancer is the 4th most common cancer in men and the 7th most common malignancy in women in Germany. 95 % of all tumors of the urinary bladder...